Results 21 to 30 of about 57,075 (256)
Human Vaccines & Immunotherapeutics, 2021 Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population.
Daniela Marín-Hernández +2 more
doaj +1 more source
Safety of BCG vaccination and revaccination in healthcare workers
Human Vaccines & Immunotherapeutics, 2023 BCG vaccination and revaccination are increasingly being considered for the protection of adolescents and adults against tuberculosis and, more broadly, for the off-target protective immunological effects against other infectious and noninfectious ...
Paola Villanueva +16 more
doaj +1 more source
Tuberculosis control by novel vaccines development and Indian initiatives
MGM Journal of Medical Sciences, 2023 Pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the worst microbial diseases of humankind and an awful societal problem, especially in underdeveloped countries.
Prasanta Kumar Ghosh
doaj +1 more source
Effectiveness of booster BCG vaccination in preventing Covid-19 infection
Human Vaccines & Immunotherapeutics, 2021 The evidence that BCG (bacille Calmette-Guerin) vaccine may increase the ability of the immune system to fight off pathogens other than tuberculosis has been studied in the past.
lradj Amirlak +5 more
doaj +1 more source
Société Internationale d’Urologie Journal, 2022 There is a critical need to establish reference response rates following bladder-sparing therapies administered in the setting of bacillus Calmete-Guerin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC).
Kyle M. Rose +10 more
doaj +1 more source
OncoImmunology, 2019 Background: Intravesical bacillus Calmette-Guérin (BCG) is the gold standard immunologic agent for treating patients with high-grade non-muscle invasive bladder cancer (NMIBC).
Niannian Ji +12 more
doaj +1 more source
BCG Aortitis, a Rare Complication of BCG Therapy
EJVES Vascular Forum, 2023 Intravesical Bacillus Calmette-Guerin (BCG) is an effective treatment for in situ bladder carcinomas; however, extravesical BCG infection may occur in remote organs in patients with underlying primary immunodeficiency and is a potentially serious complication in 3-5% of cases.
Joseph Haddad +4 more
openaire +3 more sources
The role of BCG in prevention of tuberculosis and the strategies to improve its immunogenicity
Health Promotion & Physical Activity, 2018 Tuberculosis (TB) remains a major public health problem and the main cause of death from the infectious diseases worldwide. Mycobacterium tuberculosis (Mtb), a causative agent of tuberculosis, is the oldest known human pathogen.
Jolanta Mazurek
doaj +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
AgricultureA substrate–product switch model was proposed to describe ethanol fermentation from longan solid waste using Candida tropicalis at an initial glucose and xylose ratio of 2 to 1. The model incorporated multiple rate equations for cell growth, sugar uptake,
Juan Feng +11 more
doaj +1 more source